{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:51:50Z","timestamp":1774713110877,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Klinikum der Universit\u00e4t M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>With increasing life expectancy, breast cancer (BC) in elderly women is rising, yet patients over 80 remain underrepresented in clinical trials. Understanding differences in the age groups is essential to avoid over- and undertreatment. This analysis investigates age-specific tumor characteristics, treatment patterns and outcomes in women aged 70\u201379 versus\u2009\u2265\u200980 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This population-based analysis included BC patients treated at LMU Breast Center and Munich Red Cross Hospital between 2004 and 2015. Clinical data of 2699 women aged 70\u201379 and those\u2009\u2265\u200980 were compared to assess differences in tumor biology, treatment approaches and time to metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Breast-conserving surgery rates remained stable over time, while sentinel lymph node biopsy use increased in both age groups. Patients aged\u2009\u2265\u200980 more frequently presented with larger tumors, underwent mastectomy, and received less systemic or axillary treatment, despite similarly high hormone-receptor positivity. Chemotherapy use peaked in 2009 and declined thereafter, whereas endocrine therapy (ET) increased steadily. Patients\u2009\u2265\u200980 received chemotherapy less often and more frequently ET alone. Across all biological subtypes, patients\u2009\u2265\u200980 were associated with higher rates of distant metastasis compared with those aged 70\u201379 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Clinical and biological differences between women aged 70\u201379 and those\u2009\u2265\u200980 underscore the need for age-adapted, individualized BC management. Treatment decisions should carefully balance expected benefit against comorbidity burden and functional status. Refining age-specific treatment strategies may help to improve outcomes and quality of life, although this analysis cannot determine the effects of specific strategies in this growing patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-026-08379-2","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:05:44Z","timestamp":1774710344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor biology, treatment patterns, and recurrence in breast cancer patients aged 70\u201379 vs\u2009\u2265\u200980 years: a large-scale registry analysis"],"prefix":"10.1007","volume":"313","author":[{"given":"F.","family":"Ganster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Schrodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ch.","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mahner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kolben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Wuerstlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Harbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Burgmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"8379_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100985","volume":"38","author":"SM Lima","year":"2021","unstructured":"Lima SM, Kehm RD, Terry MB (2021) Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns. EClinicalMedicine 38:100985","journal-title":"EClinicalMedicine"},{"issue":"3","key":"8379_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4274\/ejbh.galenos.2023.2023-5-1","volume":"19","author":"L Scheer","year":"2023","unstructured":"Scheer L, Lodi M, Ozmen T, Alghamdi K, Anyanwu S, Birendra J, Boubnider M, Costa M, Dian D, Elder E, Gebrim LH, Guo X, Heitz D, Imoto S, Ioannidou-Mouzaka L, Kaufman C, Liu H, Mbodj M, Meka E, Mundinger A, Novelli J, Ojuka D, Orda R, Ostapenko V, Pienkowski T, Podolski P, Vogel T, Yin J, Ozmen V, Schneebaum S, Mathelin C (2023) Current challenges and perspectives in breast cancer in elderly women: the senologic international society (SIS) survey. Eur J Breast Health 19(3):201\u2013209","journal-title":"Eur J Breast Health"},{"issue":"1","key":"8379_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.rpor.2012.05.005","volume":"18","author":"P Tesarova","year":"2012","unstructured":"Tesarova P (2012) Breast cancer in the elderly-should it be treated differently? Rep Pract Oncol Radiother 18(1):26\u201333","journal-title":"Rep Pract Oncol Radiother"},{"key":"8379_CR4","unstructured":"Harper-Harrison G, Carlson K, Shanahan M.M (2025). Hormone replacement therapy, StatPearls, Treasure Island (FL) with ineligible companies. Disclosure: Karen Carlson declares no relevant financial relationships with ineligible companies. Disclosure: Meaghan Shanahan declares no relevant financial relationships with ineligible companies."},{"issue":"1","key":"8379_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semradonc.2010.09.001","volume":"21","author":"BM Beadle","year":"2011","unstructured":"Beadle BM, Woodward WA, Buchholz TA (2011) The impact of age on outcome in early-stage breast cancer. Semin Radiat Oncol 21(1):26\u201334","journal-title":"Semin Radiat Oncol"},{"key":"8379_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103821","volume":"78","author":"M Schmidt","year":"2024","unstructured":"Schmidt M, Loibl S (2024) Chemotherapy in older patients with early breast cancer. Breast 78:103821","journal-title":"Breast"},{"issue":"Suppl 2(Suppl 2","key":"8379_CR7","first-page":"S259","volume":"57","author":"RA Silliman","year":"2009","unstructured":"Silliman RA (2009) When cancer in older adults is undermanaged: the breast cancer story. J Am Geriatr Soc 57(Suppl 2(Suppl 2)):S259\u2013S261","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"8379_CR8","first-page":"15","volume":"146","author":"K Boer","year":"2005","unstructured":"Boer K (2005) Effective treatment strategy in elderly breast cancer patients. Orv Hetil 146(1):15\u201321","journal-title":"Orv Hetil"},{"issue":"3","key":"8379_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000382112","volume":"10","author":"V Quiroga-Garcia","year":"2015","unstructured":"Quiroga-Garcia V, Cirauqui-Cirauqui B, Buges-Sanchez C, Luna-Tomas MA, Castella-Fernandez EM, Mariscal-Martinez A, Margeli-Vila M (2015) Primary hormone therapy in elderly women with hormone-sensitive locoregional breast cancer: endocrine therapy alone is a reasonable alternative in selected patients. Breast Care (Basel) 10(3):179\u2013183","journal-title":"Breast Care (Basel)"},{"issue":"12","key":"8379_CR10","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1200\/JCO.2009.25.9796","volume":"28","author":"MA Schonberg","year":"2010","unstructured":"Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McCarthy EP (2010) Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol 28(12):2038\u20132045","journal-title":"J Clin Oncol"},{"issue":"2","key":"8379_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ejcsup.2013.07.056","volume":"11","author":"N Turner","year":"2013","unstructured":"Turner N, Zafarana E, Sanna G, Mottino G, Biganzoli L (2013) The best treatment for older patients with breast cancer. EJC Suppl 11(2):299\u2013300","journal-title":"EJC Suppl"},{"issue":"1","key":"8379_CR12","doi-asserted-by":"publisher","first-page":"E162","DOI":"10.1097\/NCC.0000000000000896","volume":"45","author":"A Crouch","year":"2022","unstructured":"Crouch A, Champion V, Von Ah D (2022) Cognitive dysfunction in older breast cancer survivors: an integrative review. Cancer Nurs 45(1):E162\u2013E178","journal-title":"Cancer Nurs"},{"issue":"7","key":"8379_CR13","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1093\/oncolo\/oyae090","volume":"29","author":"G Oliva","year":"2024","unstructured":"Oliva G, Giustiniani A, Danesin L, Burgio F, Arcara G, Conte P (2024) Cognitive impairment following breast cancer treatments: an umbrella review. Oncologist 29(7):e848\u2013e863","journal-title":"Oncologist"},{"issue":"4","key":"8379_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/jnci\/djaa079","volume":"113","author":"RA Freedman","year":"2021","unstructured":"Freedman RA, Sedrak MS, Bellon JR, Block CC, Lin NU, King TA, Minami C, VanderWalde N, Jolly TA, Muss HB, Winer EP (2021) Weathering the storm: managing older adults with breast cancer amid COVID-19 and beyond. J Natl Cancer Inst 113(4):355\u2013359","journal-title":"J Natl Cancer Inst"},{"key":"8379_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-025-07956-1","author":"M Burgmann","year":"2025","unstructured":"Burgmann M, Hermelink K, Lotz A, Schlager V, Kolben T, Seifert C, Schrodi S, Ganster F, Koenig A, Beyer S, Mahner S, Harbeck N, Wuerstlein R (2025) Influence of breast cancer on life satisfaction in the elderly patient. Arch Gynecol Obstet. https:\/\/doi.org\/10.1007\/s00404-025-07956-1","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"8379_CR16","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/S2666-7568(21)00280-4","volume":"3","author":"N Carleton","year":"2022","unstructured":"Carleton N, Nasrazadani A, Gade K, Beriwal S, Barry PN, Brufsky AM, Bhargava R, Berg WA, Zuley ML, van Londen GJ, Marroquin OC, Thull DL, Mai PL, Diego EJ, Lotze MT, Oesterreich S, McAuliffe PF, Lee AV (2022) Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women. Lancet Healthy Longev 3(1):e54\u2013e66","journal-title":"Lancet Healthy Longev"},{"key":"8379_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4137\/CMO.S26067","volume":"9","author":"D Riseberg","year":"2015","unstructured":"Riseberg D (2015) Treating elderly patients with hormone receptor-positive advanced breast cancer. Clin Med Insights Oncol 9:65\u201373","journal-title":"Clin Med Insights Oncol"},{"issue":"2","key":"8379_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jgo.2019.09.005","volume":"11","author":"S Kadambi","year":"2020","unstructured":"Kadambi S, Soto-Perez-de-Celis E, Garg T, Loh KP, Krok-Schoen JL, Battisti NML, Moffat GT, Gil-Jr LA, Mohile S, Hsu T (2020) Social support for older adults with cancer: young internation al society of geriatric oncology review paper. J Geriatr Oncol 11(2):217\u2013224","journal-title":"J Geriatr Oncol"},{"key":"8379_CR19","unstructured":"National Academies of Sciences, Engineering, and Medicine; Division of Behavioral and Social Sciences and Education; Health and Medicine Division; Board on behavioral, cognitive, and sensory sciences; board on health sciences policy; committee on the health and medical dimensions of social isolation and loneliness in older adults. Social isolation and loneliness in older adults: opportunities for the health care system. Washington (DC): National Academies Press (US). (2020) 4, risk and protective factors for social isolation and Loneliness. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557971\/."},{"issue":"1","key":"8379_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10549-014-2917-7","volume":"145","author":"M Kiderlen","year":"2014","unstructured":"Kiderlen M, de Glas NA, Bastiaannet E, van de Water W, de Craen AJ, Guicherit OR, Merkus JW, Extermann M, van de Velde CJ, Liefers GJ (2014) Impact of comorbidity on outcome of older breast cancer patients: a FOCUS cohort study. Breast Cancer Res Treat 145(1):185\u2013192. https:\/\/doi.org\/10.1007\/s10549-014-2917-7. (Epub 2014 Mar 28. PMID: 24676624.)","journal-title":"Breast Cancer Res Treat"},{"key":"8379_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/CIA.S50670","volume":"10","author":"O Le Saux","year":"2015","unstructured":"Le Saux O, Ripamonti B, Bruyas B, Bonin O, Freyer G, Bonnefoy M, Falandry C (2015) Optimal management of breast cancer in the elderly patient: current perspectives. Clin Interv Aging 10:157\u2013174. https:\/\/doi.org\/10.2147\/CIA.S50670. (PMID: 25609933; PMCID: PMC4293298.)","journal-title":"Clin Interv Aging"},{"issue":"5","key":"8379_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/07357907.2016.1182184","volume":"34","author":"R K\u00f6nigsberg","year":"2016","unstructured":"K\u00f6nigsberg R, Pfeiler G, Hammerschmid N, Holub O, Gl\u00f6ssmann K, Larcher-Senn J, Dittrich C (2016) Breast cancer subtypes in patients aged 70 years and older. Cancer Invest 34(5):197\u2013204. https:\/\/doi.org\/10.1080\/07357907.2016.1182184. (Epub 2016 May 23. PMID: 27215407.)","journal-title":"Cancer Invest"},{"issue":"2","key":"8379_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4048\/jbc.2024.0190","volume":"28","author":"JH Kim","year":"2025","unstructured":"Kim JH, Kim YY, Chung JH, Kim WY, Lee JB, Woo SU (2025) Breast cancer in older patients aged 70 years and above: treatment adherence and oncologic outcomes. J Breast Cancer 28(2):99\u2013107. https:\/\/doi.org\/10.4048\/jbc.2024.0190. (Epub 2025 Feb 27. PMID: 40133983; PMCID: PMC12046351.)","journal-title":"J Breast Cancer"},{"issue":"10","key":"8379_CR24","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1111\/bcp.14539","volume":"86","author":"RJ van Marum","year":"2020","unstructured":"van Marum RJ (2020) Underrepresentation of the elderly in clinical trials, time for action. Br J Clin Pharmacol 86(10):2014\u20132016. https:\/\/doi.org\/10.1111\/bcp.14539. (Epub 2020 Sep 9. PMID: 32909294; PMCID: PMC7495271.)","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"8379_CR25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1470-2045(17)30438-2","volume":"18","author":"B O'Sullivan","year":"2017","unstructured":"O\u2019Sullivan B, Brierley J, Byrd D, Bosman F, Kehoe S, Kossary C, Pineros M, Van Eycken E, Weir HK, Gospodarowicz M (2017) The TNM classification of malignant tumours-towards common understanding and reasonable expectations. Lancet Oncol 18(7):849\u2013851","journal-title":"Lancet Oncol"},{"issue":"20","key":"8379_CR26","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","volume":"36","author":"AC Wolff","year":"2018","unstructured":"Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P, Hanna W, Jenkins RB, Press MF, Spears PA, Vance GH, Viale G, McShane LM, Dowsett M (2018) Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of American pathologists clinical practice guideline focused update. J Clin Oncol 36(20):2105\u20132122","journal-title":"J Clin Oncol"},{"issue":"49","key":"8379_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/jncimonographs\/lgu024","volume":"2014","author":"AB Mariotto","year":"2014","unstructured":"Mariotto AB, Noone AM, Howlader N, Cho H, Keel GE, Garshell J, Woloshin S, Schwartz LM (2014) Cancer survival: an overview of measures, uses, and interpretation. J Natl Cancer Inst Monogr 2014(49):145\u2013186","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"3","key":"8379_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000446359","volume":"11","author":"D Malek","year":"2016","unstructured":"Malek D, K\u00e4\u00e4b-Sanyal V (2016) Implementation of the German mammography screening program (German MSP) and first results for initial examinations, 2005-2009. Breast Care Basel 11(3):183\u2013187. https:\/\/doi.org\/10.1159\/000446359. (Epub 2016 Jun 23. PMID: 27493618; PMCID: PMC4960364.)","journal-title":"Breast Care Basel"},{"issue":"8","key":"8379_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081898","volume":"14","author":"M Garutti","year":"2022","unstructured":"Garutti M, Griguolo G, Botticelli A, Buzzatti G, De Angelis C, Gerratana L, Molinelli C, Adamo V, Bianchini G, Biganzoli L, Curigliano G, De Laurentiis M, Fabi A, Frassoldati A, Gennari A, Marchi\u00f2 C, Perrone F, Viale G, Zamagni C, Zambelli A, Del Mastro L, De Placido S, Guarneri V, Marchetti P, Puglisi F (2022) Definition of high-risk early hormone-positive HER2-negative breast cancer: a consensus review. Cancers (Basel) 14(8):1898. https:\/\/doi.org\/10.3390\/cancers14081898. (PMID: 35454806; PMCID: PMC9029479.)","journal-title":"Cancers (Basel)"},{"key":"8379_CR30","unstructured":"Interdisziplin\u00e4re S3-Leitlinie f\u00fcr die Diagnostik, Therapie und Nachsorge des Mammakarzinoms, 1. Aktualisierung edn. Zuckschwerdt, Germering\/M\u00fcnchen, Germany 2008."},{"issue":"1","key":"8379_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-023-03062-1","volume":"21","author":"M Heidinger","year":"2023","unstructured":"Heidinger M, Maggi N, Dutilh G, Mueller M, Eller RS, Loesch JM, Schwab FD, Kurzeder C, Weber WP (2023) Use of sentinel lymph node biopsy in elderly patients with breast cancer - 10-year experience from a Swiss university hospital. World J Surg Oncol 21(1):176. https:\/\/doi.org\/10.1186\/s12957-023-03062-1. (PMID: 37287038; PMCID: PMC10249276.)","journal-title":"World J Surg Oncol"},{"key":"8379_CR32","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1200\/JCO-25-00099","volume":"43","author":"KU Park","year":"2025","unstructured":"Park KU et al (2025) Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline update. J Clin Oncol 43:1720\u20131741. https:\/\/doi.org\/10.1200\/JCO-25-00099","journal-title":"J Clin Oncol"},{"key":"8379_CR33","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-18631-9","author":"CE Cox","year":"2025","unstructured":"Cox CE, Schumacher J, Lillie M, Carino J, Agrawal Y, Selfridge JM, Gallagher KK, Ollila DW, Casey DL, Greenberg CC, Spanheimer PM (2025) Simultaneous omission of sentinel lymph node biopsy and radiation in older women with early ER+ breast cancer. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-025-18631-9. (Epub ahead of print. PMID: 41145934; PMCID: PMC12648279.)","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"8379_CR34","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10549-010-1329-6","volume":"126","author":"FO Ademuyiwa","year":"2011","unstructured":"Ademuyiwa FO, Miller A, O\u2019Connor T, Edge SB, Thorat MA, Sledge GW, Levine E, Badve S (2011) The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort. Breast Cancer Res Treat 126(3):797\u2013802","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"8379_CR35","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","volume":"10","author":"U Anand","year":"2023","unstructured":"Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK, De Falco V, Upadhyay A, Kandimalla R, Chaudhary A, Dhanjal JK, Dewanjee S, Vallamkondu J, Perez de la Lastra JM (2023) Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis 10(4):1367\u20131401","journal-title":"Genes Dis"},{"issue":"12","key":"8379_CR36","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41571-020-0421-z","volume":"17","author":"S Kadambi","year":"2020","unstructured":"Kadambi S, Loh KP, Dunne R, Magnuson A, Maggiore R, Zittel J, Flannery M, Inglis J, Gilmore N, Mohamed M, Ramsdale E, Mohile S (2020) Older adults with cancer and their caregivers - current landscape and future directions for clinical care. Nat Rev Clin Oncol 17(12):742\u2013755","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"8379_CR37","doi-asserted-by":"publisher","first-page":"e1516","DOI":"10.1634\/theoncologist.2019-0701","volume":"25","author":"J Feliu","year":"2020","unstructured":"Feliu J, Jimenez-Munarriz B, Basterretxea L, Paredero I, Llabres E, Antonio-Rebollo M, Losada B, Espinosa E, Girones R, Custodio AB, Del Mar Munoz M, Diaz-Almiron M, Gomez-Mediavilla J, Pinto A, Torregrosa MD, Soler G, Cruz P, Higuera O, Molina-Garrido MJ (2020) Predicting chemotherapy toxicity in older patients with cancer: a multicenter prospective study. Oncologist 25(10):e1516\u2013e1524","journal-title":"Oncologist"},{"key":"8379_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225643","author":"N Nabieva","year":"2021","unstructured":"Nabieva N, Fasching PA (2021) Endocrine treatment for breast cancer patients revisited-history, standard of care, and possibilities of improvement. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13225643","journal-title":"Cancers (Basel)"},{"key":"8379_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174287","author":"S Lukasiewicz","year":"2021","unstructured":"Lukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanislawek A (2021) Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13174287","journal-title":"Cancers (Basel)"},{"issue":"Suppl 3(0 3)","key":"8379_CR40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1245\/s10434-010-1253-3","volume":"17","author":"M Yi","year":"2010","unstructured":"Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, Hwang RF, Bedrosian I, Rourke L, Hunt KK (2010) Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol 17(Suppl 3(0 3)):343\u2013351","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"8379_CR41","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12957-023-03062-1","volume":"21","author":"M Heidinger","year":"2023","unstructured":"Heidinger M, Maggi N, Dutilh G, Mueller M, Eller RS, Loesch JM, Schwab FD, Kurzeder C, Weber WP (2023) Use of sentinel lymph node biopsy in elderly patients with breast cancer - 10-year experience from a Swiss university hospital. World J Surg Oncol 21(1):176","journal-title":"World J Surg Oncol"},{"issue":"3","key":"8379_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","volume":"5","author":"O Yersal","year":"2014","unstructured":"Yersal O, Barutca S (2014) Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol 5(3):412\u2013424","journal-title":"World J Clin Oncol"},{"issue":"4","key":"8379_CR43","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/j.clbc.2024.01.016","volume":"24","author":"YH You","year":"2024","unstructured":"You YH, Kim MK, Lee JY (2024) Prognosis and adjusting factors in elderly patients with Triple-Negative Breast Cancer: comparing with young and middle age groups. Clin Breast Cancer 24(4):e258\u2013e265","journal-title":"Clin Breast Cancer"},{"key":"8379_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092392","author":"GK Gupta","year":"2020","unstructured":"Gupta GK, Collier AL, Lee D, Hoefer RA, Zheleva V, Siewertsz van Reesema LL, Tang-Tan AM, Guye ML, Chang DZ, Winston JS, Samli B, Jansen RJ, Petricoin EF, Goetz MP, Bear HD, Tang AH (2020) Perspectives on triple-negative breast cancer: current treatment strategies, unmet needs, and potential targets for future therapies. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12092392","journal-title":"Cancers (Basel)"},{"key":"8379_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153697","author":"Q Wu","year":"2021","unstructured":"Wu Q, Siddharth S, Sharma D (2021) Triple negative breast cancer: a mountain yet to be scaled despite the triumphs. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13153697","journal-title":"Cancers (Basel)"},{"issue":"12","key":"8379_CR46","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","volume":"32","author":"A Gennari","year":"2021","unstructured":"Gennari A, Andre F, Barrios CH, Cortes J, de Azambuja E, DeMichele A, Dent R, Fenlon D, Gligorov J, Hurvitz SA, Im SA, Krug D, Kunz WG, Loi S, Penault-Llorca F, Ricke J, Robson M, Rugo HS, Saura C, Schmid P, Singer CF, Spanic T, Tolaney SM, Turner NC, Curigliano G, Loibl S, Paluch-Shimon S, Harbeck N (2021) ESMO clinical practice guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer. Ann Oncol 32(12):1475\u20131495","journal-title":"Ann Oncol"},{"issue":"4","key":"8379_CR47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jgo.2015.12.002","volume":"7","author":"GR Williams","year":"2016","unstructured":"Williams GR, Mackenzie A, Magnuson A, Olin R, Chapman A, Mohile S, Allore H, Somerfield MR, Targia V, Extermann M, Cohen HJ, Hurria A, Holmes H (2016) Comorbidity in older adults with cancer. J Geriatr Oncol 7(4):249\u2013257","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"8379_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2901","volume":"13","author":"JL Patnaik","year":"2011","unstructured":"Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD (2011) Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 13(3):R64","journal-title":"Breast Cancer Res"},{"issue":"6","key":"8379_CR49","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.trecan.2020.12.010","volume":"7","author":"G Panigrahi","year":"2021","unstructured":"Panigrahi G, Ambs S (2021) How comorbidities shape cancer biology and survival. Trends Cancer 7(6):488\u2013495","journal-title":"Trends Cancer"},{"issue":"11","key":"8379_CR50","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s11912-022-01311-2","volume":"24","author":"R Bhatia","year":"2022","unstructured":"Bhatia R, Holtan S, Jurdi NE, Prizment A, Blaes A (2022) Do cancer and cancer treatments accelerate aging? Curr Oncol Rep 24(11):1401\u20131412","journal-title":"Curr Oncol Rep"},{"key":"8379_CR51","doi-asserted-by":"publisher","first-page":"1695101","DOI":"10.1155\/2017\/1695101","volume":"2017","author":"S Chang","year":"2017","unstructured":"Chang S, Goldstein NE, Dharmarajan KV (2017) Managing an older adult with cancer: considerations for radiation oncologists. Biomed Res Int 2017:1695101","journal-title":"Biomed Res Int"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08379-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-026-08379-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08379-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:05:46Z","timestamp":1774710346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-026-08379-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8379"],"URL":"https:\/\/doi.org\/10.1007\/s00404-026-08379-2","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is an observational analysis. The Research Ethics Committee of the Munich University Hospital has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As this is an observational analysis, no informed consent was required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Content to participate"}}],"article-number":"145"}}